Publication Information (EuropePMC) | |
Title | Polygenic risk and hazard scores for Alzheimer's disease prediction. |
PubMed ID | 30911569(Europe PMC) |
doi | 10.1002/acn3.716 |
Publication Date | Feb. 18, 2019 |
Journal | Ann Clin Transl Neurol |
Author(s) | Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J, GERAD consortium, Hardy J, Escott-Price V. |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000876 (PRS31_AD) |
PGP000222 | Leonenko G et al. Ann Clin Transl Neurol (2019) |
Alzheimer's disease | Alzheimer disease | 31 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000876/ScoringFiles/PGS000876.txt.gz |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000026 (PHS) |
PGP000016 | Desikan RS et al. PLoS Med (2017) |
Alzheimer's disease | Alzheimer disease | 33 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000026/ScoringFiles/PGS000026.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM002504 | PGS000026 (PHS) |
PSS001127| European Ancestry| 8,415 individuals |
PGP000222 | Leonenko G et al. Ann Clin Transl Neurol (2019) |Ext. |
Reported Trait: Age at Alzheimer's disease onset | β: 0.11 (0.02) | — | — | Gender, PCs (1-3), APOE(ε2 + ε4) | Due to SNP availability issues in the dataset, only 25 out of the 31 variants in Desikan et al's polygenic hazard score (PGS000026) were used. No APOE alleles were included |
PPM002505 | PGS000876 (PRS31_AD) |
PSS001127| European Ancestry| 8,415 individuals |
PGP000222 | Leonenko G et al. Ann Clin Transl Neurol (2019) |
Reported Trait: Age at Alzheimer's disease onset | β: 0.13 (0.02) | — | — | Gender, PCs (1-3), APOE(ε2 + ε4) | Due to SNP availability issues in the dataset, only 25 out of the 31 variants used to construct the polygenic risk score were used. |
PPM002506 | PGS000876 (PRS31_AD) |
PSS001125| European Ancestry| 9,903 individuals |
PGP000222 | Leonenko G et al. Ann Clin Transl Neurol (2019) |
Reported Trait: Age at Alzheimer's disease onset | β: 0.28 (0.04) | — | — | Gender, PCs (1-3), APOE ε2, APOE ε4 | — |
PPM002507 | PGS000876 (PRS31_AD) |
PSS001126| European Ancestry| 4,100 individuals |
PGP000222 | Leonenko G et al. Ann Clin Transl Neurol (2019) |
Reported Trait: Age at Alzheimer's disease onset in individuals above the age of 55 | β: 0.29 (0.03) | — | — | Gender, PCs (1-3), APOE ε2, APOE ε4 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001125 | Cases included individuals with Alzheimer's disease. | — | [
|
— | European | — | 11 cohorts
|
— |
PSS001126 | All individuals were aged 55 and above. Cases include individuals with Alzheimer's disease. | — | [
|
— | European | — | 11 cohorts
|
— |
PSS001127 | Cases included individuals with Alzheimer's disease. | — | [
|
— | European | — | 11 cohorts
|
— |